Brown Brothers Harriman & CO Moderna, Inc. Transaction History

Brown Brothers Harriman & CO

$12.7 Billion
Q2 2024

A detailed history of Brown Brothers Harriman & CO transactions in Moderna, Inc. stock. As of the latest transaction made, Brown Brothers Harriman & CO holds 656 shares of MRNA stock, worth $43,132. This represents 0.0% of its overall portfolio holdings.

Number of Shares

656

Previous 708 7.34%

Holding current value

$43,132

Previous $75,000 2.67%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	SELL	$101.21 - $166.61 $5,262 - $8,663	-52 Reduced 7.34%	656 $77,000
Q1 2024 May 10, 2024	BUY	$85.37 - $115.44 $16,988 - $22,972	199 Added 39.1%	708 $75,000
Q4 2023 Feb 12, 2024	SELL	$69.51 - $104.43 $28,499 - $42,816	-410 Reduced 44.61%	509 $50,000
Q3 2023 Nov 13, 2023	SELL	$96.41 - $126.61 $19,282 - $25,322	-200 Reduced 17.87%	919 $94,000
Q2 2023 Aug 07, 2023	SELL	$118.5 - $160.53 $59,961 - $81,228	-506 Reduced 31.14%	1,119 $135,000
Q1 2023 May 11, 2023	SELL	$135.66 - $197.02 $12,480 - $18,125	-92 Reduced 5.36%	1,625 $249,000
Q4 2022 Feb 09, 2023	SELL	$118.38 - $210.04 $11,127 - $19,743	-94 Reduced 5.19%	1,717 $308,000
Q3 2022 Nov 10, 2022	BUY	$118.07 - $194.18 $4,604 - $7,573	39 Added 2.2%	1,811 $214,000
Q2 2022 Aug 11, 2022	BUY	$117.13 - $176.59 $7,613 - $11,478	65 Added 3.81%	1,772 $253,000
Q1 2021 May 13, 2021	BUY	$109.18 - $185.98 $142,698 - $243,075	1,307 Added 326.75%	1,707 $224,000
Q3 2020 Nov 16, 2020	SELL	$54.34 - $94.85 $58,361 - $101,868	-1,074 Reduced 72.86%	400 $28,000
Q2 2020 Aug 13, 2020	BUY	$29.67 - $80.0 $31,865 - $85,920	1,074 Added 268.5%	1,474 $95,000
Q1 2020 May 15, 2020	BUY	$17.78 - $31.58 $7,112 - $12,632	400 New	400 $12,000

Others Institutions Holding MRNA

# of Institutions

1,113

Shares Held

241M

Call Options Held

9.26M

Put Options Held

12.1M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Brown Brothers Harriman & CO, based on Form 13F filings with the SEC.

News

Stay updated on Brown Brothers Harriman & CO with notifications on news.

Account

Brown Brothers Harriman & CO Moderna, Inc. Transaction History